1. Home
  2. KVUE vs TCOM Comparison

KVUE vs TCOM Comparison

Compare KVUE & TCOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$17.19

Market Cap

34.9B

ML Signal

HOLD

TCOM

Trip.com Group Limited

HOLD

Current Price

$50.30

Market Cap

34.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVUE
TCOM
Founded
2022
1999
Country
United States
Singapore
Employees
N/A
41073
Industry
Specialty Chemicals
Hotels/Resorts
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
34.9B
34.2B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
KVUE
TCOM
Price
$17.19
$50.30
Analyst Decision
Buy
Strong Buy
Analyst Count
11
8
Target Price
$19.73
$78.75
AVG Volume (30 Days)
20.0M
2.5M
Earning Date
05-07-2026
05-18-2026
Dividend Yield
4.84%
0.59%
EPS Growth
40.74
N/A
EPS
0.76
N/A
Revenue
$15,124,000,000.00
N/A
Revenue This Year
$4.82
$15.86
Revenue Next Year
$2.61
$13.00
P/E Ratio
$22.59
$9.06
Revenue Growth
N/A
N/A
52 Week Low
$14.02
$48.48
52 Week High
$25.17
$79.00

Technical Indicators

Market Signals
Indicator
KVUE
TCOM
Relative Strength Index (RSI) 36.08 40.58
Support Level $16.73 $49.48
Resistance Level $17.20 $54.24
Average True Range (ATR) 0.30 1.01
MACD -0.04 0.17
Stochastic Oscillator 21.16 45.15

Price Performance

Historical Comparison
KVUE
TCOM

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.

About TCOM Trip.com Group Limited

Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 79% of sales from accommodation reservations and transportation ticketing in 2024. The rest of revenue comes from package tours and corporate travel. Before the pandemic in 2019, the company generated 25% of revenue from international travel, which is important to its margin expansion. Most of sales come from its domestic platform, but the company is expanding its overseas business. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Tongcheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.

Share on Social Networks: